IP Library Granted Patent US 7,985,583
Granted Patent B2
US 7,985,583 · App. 12/481,536 · Granted Jul 26, 2011

Chlamydomonas intraflagellar transport 88 (IFT-88)

Assignees: Univeristy of Massachusetts; Yale University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,985,583
App. No.
12/481,536
Granted
Jul 26, 2011
Kind
B2
Abstract

The invention relates to various intraflagellar transport (IFT) polypeptides and the nucleic acids that encode them. The new IFT particle polypeptides and nucleic acids can be used in a variety, of diagnostic, screening, and therapeutic methods.

Claims (18)

1. An isolated nucleic acid molecule comprising a nucleotide sequence that encodes a Chlamydomonas intraflagellar transport (IFT) particle protein 88 that is at least 95% identical to SEQ ID NO:16, or the full-length complement thereof.

2. The isolated nucleic acid molecule of claim 1 , comprising a sequence at least 95% identical to nucleotides 108-2456 of SEQ ID NO:15, or the full-length complement thereof.

3. The isolated nucleic acid molecule of claim 1 , consisting essentially of a sequence at least 95% identical to nucleotides 108-2456 of SEQ ID NO:15, or the full-length complement thereof.

4. The isolated nucleic acid molecule of claim 1 , consisting essentially of a sequence at least 95% identical to SEQ ID NO:15, or the full-length complement thereof

5. The isolated nucleic acid molecule of claim 1 , further comprising a nucleic acid sequence encoding a heterologous polypeptide.

6. A vector comprising the nucleic acid molecule of claim 1 .

7. An isolated host cell comprising the nucleic acid molecule of claim 1 .

8. The isolated host cell of claim 7 , wherein the host cell is a non-human mammalian host cell.

9. The isolated nucleic acid molecule of claim 2 , further comprising a nucleic acid sequence encoding a heterologous polypeptide.

10. A vector comprising the nucleic acid molecule of claim 2 .

11. An isolated host cell comprising the nucleic acid molecule of claim 2 .

12. The isolated host cell of claim 11 , wherein the host cell is a non-human mammalian host cell.

13. A vector comprising the nucleic acid molecule of claim 3 .

14. An isolated host cell comprising the nucleic acid molecule of claim 3 .

15. The isolated host cell of claim 14 , wherein the host cell is a non-human mammalian host cell.

16. A vector comprising the nucleic acid molecule of claim 4 .

17. An isolated host cell comprising the nucleic acid molecule of claim 4 .

18. The isolated host cell of claim 17 , wherein the host cell is a non-human mammalian host cell.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jan 4, 2013
From: UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029572/0226 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2011
From: UNIVERSITY OF MASSACHUSETTS
To: UNIVERSITY OF MASSACHUSETTS; YALE UNIVERSITY
Reel/Frame 025949/0265 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2009
From: WITMAN, GEORGE B.; PAZOUR, GREGORY J.; ROSENBAUM, JOEL L.; COLE, DOUGLAS G.
To: UNIVERSITY OF MASSACHUSETTS
Reel/Frame 022837/0708 →
Continuity (4)
Division 10839016 · May 5, 2004
Continuation 09866582 · May 24, 2001
Provisional Application 60206923 · May 24, 2000
Related Publication 20100267130A1 · Oct 21, 2010